Frank Litvack , MD

Chairman & CEO
Conor Medsystems, Inc.
Menlo Park

Dr. Litvack received his doctorate in medicine from McGill University in 1979 and is Professor of Medicine at UCLA. Board certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology, Dr. Litvack co- directed the Cardiovascular Intervention Center at Cedars-Sinai from 1986 until 2000. A nationally recognized leader in cardiovascular research, he has published several hundred articles, chapters and abstracts. A prolific entrepreneur, Dr. Litvack has founded several successful interventional cardiology companies: Advanced Interventional Systems (AIS), where he developed the first FDA-approved excimer laser angioplasty system; Progressive Angioplasty Systems (PAS), which was acquired by US Surgical for $150 million; and, Immusol, which has raised nearly $100 million and has been featured in the Wall Street Journal several times for its significant discoveries and pharmaceutical partnerships. Dr. Litvack is a General Partner in Calmedica Capital, a closely- held partnership that invests in technology start-ups. He is currently the Chairman of the Board of Savacor, a start-up medical device company addressing the congestive heart failure market, and Fasturn, a software development company.